Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting “substance P-hepatic stellate cells-hepatocellular carcinoma” axis
Zhipeng Li, Fangqing Wang, Yanying Li, et al.
Biomaterials (2021) Vol. 276, pp. 121003-121003
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies
Hailong Tian, Tingting Zhang, Siyuan Qin, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 239
Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework
Weilun Pan, Yong Tan, Wei Meng, et al.
Biomaterials (2022) Vol. 283, pp. 121449-121449
Closed Access | Times Cited: 160
Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
Changyu Yao, Shilun Wu, Jian Kong, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 1, pp. 25-43
Open Access | Times Cited: 70
Metal-organic framework decorated with glycyrrhetinic acid conjugated chitosan as a pH-responsive nanocarrier for targeted drug delivery
Liu Cui, Xi Wang, Zhaoyun Liu, et al.
International Journal of Biological Macromolecules (2023) Vol. 240, pp. 124370-124370
Closed Access | Times Cited: 56
Multi-stage mechanisms of tumor metastasis and therapeutic strategies
Zaoqu Liu, Jingqi Chen, Yuqing Ren, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Recent advances in anti-multidrug resistance for nano-drug delivery system
Changduo Wang, Fashun Li, Tianao Zhang, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1684-1697
Open Access | Times Cited: 46
Recent Advances in Glycyrrhetinic Acid-Functionalized Biomaterials for Liver Cancer-Targeting Therapy
Antonio Speciale, Claudia Muscarà, Maria Sofia Molonia, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 1775-1775
Open Access | Times Cited: 40
Anti-stromal nanotherapeutics for hepatocellular carcinoma
Zhuo Yu, Leaf Huang, Jianfeng Guo
Journal of Controlled Release (2024) Vol. 367, pp. 500-514
Closed Access | Times Cited: 10
Nanomedicine Strategies to Circumvent Intratumor Extracellular Matrix Barriers for Cancer Therapy
Xiaoxuan Xu, Yao Wu, Xindi Qian, et al.
Advanced Healthcare Materials (2021) Vol. 11, Iss. 1
Closed Access | Times Cited: 44
GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma
Yanying Li, Jingliang Wu, Lu Qiao, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 2559-2575
Open Access | Times Cited: 30
Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma
Zishuai Li, Zihan Zhang, Letian Fang, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 2083-2099
Open Access | Times Cited: 17
Combination of polythyleneimine regulating autophagy prodrug and Mdr1 siRNA for tumor multidrug resistance
Changduo Wang, Zhipeng Li, Ping Xu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 22
Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma
Adriana G. Quiroz-Reyes, Sonia Amelia Lozano Sepúlveda, Natalia Martínez-Acuña, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 15
Potential of capsaicin as a combinatorial agent to overcome chemoresistance and to improve outcomes of cancer therapy
Bethsebie Lalduhsaki Sailo, Anushka Garhwal, Abinash Mishra, et al.
Biochemical Pharmacology (2025), pp. 116828-116828
Open Access
Efficiency co-delivery of ellagic acid and oxygen by a non-invasive liposome for ameliorating diabetic retinopathy
Zhipeng Li, Hongli Yu, Chaolong Liu, et al.
International Journal of Pharmaceutics (2023) Vol. 641, pp. 122987-122987
Closed Access | Times Cited: 11
Enhancing Temozolomide Efficacy in GBM: The Synergistic Role of Chuanxiong Rhizoma Essential Oil
Gang Ke, Pengyi Hu, Hui Xiong, et al.
Phytomedicine (2025) Vol. 140, pp. 156575-156575
Closed Access
Redefining Hepatocellular Carcinoma Treatment: Nanotechnology Meets Tumor Immune Microenvironment
Chen Mi, Sai Liu, Zhida Chen
Journal of drug targeting (2025), pp. 1-47
Closed Access
Suprabasin promotes gastric cancer liver metastasis via hepatic stellate cells-mediated EGF/CCL2/JAK2 intercellular signaling pathways
Difeng Li, Zhiqing Gao, Zhuojun Zhang, et al.
Oncogene (2025)
Closed Access
Nanotechnology strategies for hepatocellular carcinoma diagnosis and treatment
Weilu Jia, YingHui Han, Xinyu Mao, et al.
RSC Advances (2022) Vol. 12, Iss. 48, pp. 31068-31082
Open Access | Times Cited: 18
Modulating tumor-stromal crosstalk via a redox-responsive nanomedicine for combination tumor therapy
Yuxin Zhang, Jie Zhou, Xiaoting Chen, et al.
Journal of Controlled Release (2023) Vol. 356, pp. 525-541
Closed Access | Times Cited: 10
Anti-tumor therapy of glycyrrhetinic acid targeted liposome co-delivery of doxorubicin and berberine for hepatocellular carcinoma
Na Xu, Jingliang Wu, Weihao Wang, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 9, pp. 2386-2402
Closed Access | Times Cited: 3
Hyaluronic Acid-Mediated Phenolic Compound Nanodelivery for Cancer Therapy
Simona Serini, Sonia Trombino, Federica Curcio, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1751-1751
Open Access | Times Cited: 7
SP94 engineered erythrocyte membrane enhanced the targeted delivery of biomimetic nanosuspension with IDO immunotherapy and chemotherapy in liver cancer
Faisal Raza, Liangdi Jiang, Steven S.-L. Zhang, et al.
Chemical Engineering Journal (2024) Vol. 491, pp. 151709-151709
Closed Access | Times Cited: 2
Development and efficacy evaluation of nanoliposomes targeting CAFs-LCSCs communication for hepatocellular carcinoma treatment
Liang Kong, Yang Yu, Ru Yang, et al.
Chemical Engineering Journal (2024) Vol. 496, pp. 154173-154173
Closed Access | Times Cited: 2
Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies
Esraa Ali, Andriy Trailin, Filip Ambrożkiewicz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15292-15292
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top